Evidence map›Paper›PMID 32089976›Full record

ArticleCureus2020

The Carotenoid Compound of Saffron Crocetin Alleviates Effects of Ischemia Reperfusion Injury via a Mechanism Possibly Involving MiR-127.

Constantinos P Michael, Michael Derpapas, Eftychia Aravidou, Michael Sofopoulos, Panayiotis Michael, Andreas Polydorou, Antonios Vezakis, Georgios P Fragulidis

Open access · diamondAbstract read
In one paragraph

Article in Cureus, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Crocetin: A Systematic Review.Frontiers in pharmacology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Constantinos P MichaelMedicine, National and Kapodistrian University of Athens School of Medicine, Athens, GRC.
Michael DerpapasBreast Surgery, REA Maternity Hospital, Athens, GRC.
Eftychia AravidouSurgery, Aretaeio Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, GRC.
Michael SofopoulosPathology, "Saint Savvas" Regional Anticancer Hospital, Athens, GRC.
Panayiotis MichaelMathematics, Cyprus Ministry of Education and Culture, Nicosia, CYP.
Andreas PolydorouSurgery, Aretaeio Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, GRC.
Antonios VezakisSurgery, Aretaeio Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, GRC.
Georgios P FragulidisSurgery, Aretaeio Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, GRC.
Aretaeio Hospital · GRLETO Maternity Hospital · GRLimassol General Hospital · CYSt Savas Hospital · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal impairment is associated with high mortality rates in severely ill patients. The need to prevent and treat renal damage underlines the importance of understanding the pathophysiological mechanisms that characterize it. This could also enable early diagnosis and the design of alternative therapeutic approaches. The aim of this study is to investigate the effect of crocetin, a known antioxidant, on the prevention of renal damage due to ischemia-reperfusion injury and the investigation of the mechanisms involved. The present study was performed on C57BL/6 mice aged 10-12 weeks. The animals had access to water and food ad libitum. The experiment, as described in materials and methods, was completed at 24 h, in which case the kidneys were removed for further study, both at tissue morphology (with immunohistochemistry) and changes in the level of miRs' expression by qRT-PCR. Accordingly, using the automatic precision analyzer, the serum levels of the basic parameters currently used clinically for the monitoring of renal function were determined. The administration of crocetin, despite the short presence of the substance in the body, affects all the biochemical parameters analyzed (urea, creatinine, uric acid, and ions of Na, K, Cl, P, Mg and Ca), ​​causing significant decrease of their measured values. Crocetin also resulted in a significant limitation of the inflammation elements and the degree of epithelial damage. Furthermore, the administration of crocetin appears to restore levels of expression of miR21, miR127 and miR132.

Indexed as

crocetininjuryischemiaischemic shockmicrornasmir-127pcrrenal failurereperfusionsaffron

Identifiers

PMID32089976
PMCPMC7017928
OpenAlexW3005845300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.